Loading organizations...
Loading organizations...
Allogeneic platform for immune therapy to prevent cancer resistance.
Brenus Pharma has raised $25.0M across 1 funding round.
Brenus Pharma has raised $25.0M in total across 1 funding round.
Brenus Pharma has raised $25.0M in total across 1 funding round.
Brenus Pharma's investors include Angelor.
Brenus Pharma has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series A in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 18, 2024 | $25.0M Series A | Angelor |